circulating DNA/RNA | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

11,989 results for “circulating DNA/RNA”

Circulating DNA/RNA Market Set to Triple to $16.4 Billion by 2032, Driven by Patent Innovations

ANGLE's Parsortix System Enables Breakthrough Cancer Research Revealing CTC Clusters as Key Metastatic Drivers

Nine-Marker Molecular Signature Identified as Driver of Lapatinib Resistance in HER2-Positive Breast Cancer

Circulating Tumor DNA Testing Transforms Breast Cancer Monitoring and Treatment Selection

Biologic Therapies Remodel Immune Cell Transcriptional Profiles in Severe Eosinophilic Asthma

Molecular Testing and Circulating Tumor DNA Advances Set to Transform GIST Management

Circulating Tumor DNA Emerges as Powerful Prognostic Biomarker in Locally Advanced Cervical Cancer

ctDNA Monitoring Shows Promise in Stage III BRAF-Mutant Melanoma

Genomic Profiling of HER2-Low Metastatic Breast Cancer Reveals Potential Therapeutic Strategies

ctDNA Analysis Shows Promise in Early-Stage NSCLC Management

Page 1 of 431